The US Patent and Trademark Office (USPTO) has launched the Cancer Immunotherapy programme to expedite examination of patent applications covering therapies that activate the immune system to kill cancer cells.
The programme opened last month in support of President Barack Obama’s ‘National Cancer Moonshot’, under which an extra $1 billion will be pumped into R&D in the field, to double the volume of cancer research over the next 10 years.
